Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dodick

Showing results (371-380 of 620) with videos related to

Pageof 62
Sort By:
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
The Lancet. Neurology|December 16, 2014
Site of effect of LY2951742 for migraine prophylaxis--authors' replyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
Headache|May 11, 2019
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter TrialDavid Yarnitsky, David W Dodick, Brian M Grosberg, et al.
The Lancet. Neurology|August 16, 2014
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled studyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
Headache|February 27, 2024
Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experienceNikita Chhabra, Carolyn Mead-Harvey, Christopher A Dodoo, et al.
Cephalalgia : an International Journal of Headache|March 27, 2007
Treatment-emergent CNS symptoms following triptan therapy are part of the attackP J Goadsby, D W Dodick, M Almas, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Headache|April 21, 2007
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapyStephen D Silberstein, David Dodick, Fred Freitag, et al.
Neurology|March 11, 2009
ACGME competencies in neurology: web-based objective simulated computerized clinical encountersK M Kash, B F Leas, J Clough, et al.
Journal of Neurology|March 12, 2005
The use of multiattribute decision models in evaluating triptan treatment options in migraineM D Ferrari, P J Goadsby, R B Lipton, et al.
Pageof 62

Showing results (371-380 of 620) with videos related to

Sort By:
Pageof 62
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
The Lancet. Neurology|December 16, 2014
Site of effect of LY2951742 for migraine prophylaxis--authors' replyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
Headache|May 11, 2019
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter TrialDavid Yarnitsky, David W Dodick, Brian M Grosberg, et al.
The Lancet. Neurology|August 16, 2014
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled studyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
Headache|February 27, 2024
Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experienceNikita Chhabra, Carolyn Mead-Harvey, Christopher A Dodoo, et al.
Cephalalgia : an International Journal of Headache|March 27, 2007
Treatment-emergent CNS symptoms following triptan therapy are part of the attackP J Goadsby, D W Dodick, M Almas, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Headache|April 21, 2007
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapyStephen D Silberstein, David Dodick, Fred Freitag, et al.
Neurology|March 11, 2009
ACGME competencies in neurology: web-based objective simulated computerized clinical encountersK M Kash, B F Leas, J Clough, et al.
Journal of Neurology|March 12, 2005
The use of multiattribute decision models in evaluating triptan treatment options in migraineM D Ferrari, P J Goadsby, R B Lipton, et al.
Pageof 62